Method for prophylaxis of influenza using vaccine for intranasal administration
US9603919B2 · kind B2 · utility
0Cited by
4References
27Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 31, 2010 |
| Grant date | Mar 28, 2017 |
| Priority date | — |
| Expiry date | Mar 31, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a vaccine composition for transnasal mucous membrane administration, which contains an influenza virus antigen, polyriboinosinic polyribocytidylic acid (poly (I:C)) or a derivative thereof and a carboxyvinyl polymer. The present invention also provides a prophylactic method of influenza, including a step of administering the vaccine composition at least once to the nasal mucosa of a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.